Reaktioner på injektionsstedet (ISR) var de hyppigst rapporterede bivirkninger, og de indtraf hos 98% patienterne (tabel 2).
Injection site reactions (ISRs) were the most frequently reported adverse reaction and occurred in 98% of the patients (Table 2).